Current Edition

Serialisation: Headache or Opportunity?

The scourge of counterfeit drugs continues to threaten global health programmes. When it comes to dealing with the impact of counterfeit trade, there is an increasingly heavy burden placed upon healthcare systems, healthcare professionals, national medicine regulatory authorities, law enforcement agencies and criminal justice systems. To counter this growing threat, Gaurav Mohite at ACG Worldwide reveals that government bodies are enacting more robust and stricter regulations to control the genesis and proliferation of fake medicines.